A surveillance system for the real-time reporting of influenza activity

Disease Management and Health Outcomes

Volumn 12, Issue 3, 2004, Pages 197-206

  Uphoff, Helmut ^a,b,c,d   Groniewicz, Irena ^b   Soriano, Marc ^b   Burckhardt Batista, Isabel ^b  

^a Deutches Grünes Kreuz   (Germany)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c Europ Influenza Surveillance Scheme   (Germany)

^d NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; GERMANY; HEALTH SURVEY; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HUMAN; INFLUENZA; INFORMATION PROCESSING; MORBIDITY; STANDARDIZATION;

EID: 3042587915     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-200412030-00006     Document Type: Article

References (22)

1. Barker WH, Mulloly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol. 1980; 112: 798-813
2. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2000; 49 (RR-04): 1-38
3. Simonsen L, Fukuda K, Schoenberger LB, et al. Impact of influenza epidemics on hospitalizations. J Infect Dis 2000; 181: 831-7
4. Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet 2000; 355: 827-35
5. Nicholson KG, Aoki FY, Osterhaus ADME, et al. Treatment of acute influenza: efficacy and safety of the oral neuraminidase inhibitor oseltamivir. Lancet 2000; 355: 1845-50
6. Aoki F, MacLeod M, Paggiaro P, et al. Maximising benefits of influenza treatment with oral oseltamivir: results of the IMPACT study. J Antimicrob Chemother 2003; 51: 123-9
7. Lange W, Uphoff H, Behrens M. Practicability and costs of on-site testing during an influenza epidemic [abstract W8-6]. European Scientific Working Group on Influenza. First European Influenza Conference, ESWI; 2002 Oct 20-23; Malta
8. Fleming D, Wood M. The clinical diagnosis of influenza. Curr Med Res Opin 2002; 18: 338-41
9. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza. JAMA 2000; 283: 1016-24
10. Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001; 20: 127-33
11. Hayden FG, Osterhaus ADME, Treanor JJ, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. N Engl J Med 1997; 337: 874-80
12. Monto AS, Fleming DM, Henry D, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections. J Infect Dis 1999; 180: 254-61
13. Mäkelä MJ, Pauksens K, Rostila T, et al. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study. J Infect 2000; 40: 42-8
14. Zambon M, Hays J, Webster A, et al. Diagnosis of influenza in the community. Arch Intern Med 2001; 161: 2116-22
15. Data on file, Roche, 2004
16. Influenza A/B Rapid Test package insert. Mannheim: Roche Diagnostics GmbH, 2002
17. ArbeitsGemeinschaft Influenza. Abschlussbericht der Influenzasaison 2001/02, Berlin 2002 [online]. Available from URL: http://www.dgk.de/agi/ [Accessed 2004 Mar 30]
18. Snacken R. Managing influenza in primary care: a practical guide to clinical diagnosis. Dis Manage Health Outcomes 2000; 8: 79-85
19. Thomas Y, Kaiser L, Mueller D, et al. Surveillance of influenza epidemics between 1999 and 2002 using a rapid antigen detection test. First European Influenza Conference, ESWI; 2002 Oct 20-23; Malta
20. Carman WF, Wallace LA, Walker J, et al. Rapid virological surveillance of community influenza infection in general influenza. BMJ 2000; 321: 736-7
21. Aoki FY, Macleod MD, Paggiaro P, et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 2003; 51: 123-9
22. Kaiser L, Wat C, Mills T, et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003; 163: 1667-72